Zymeworks (ZYME) Income from Continuing Operations (2021 - 2026)

Zymeworks has disclosed Income from Continuing Operations across 6 years of filings, most recently posting 44162000.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 44162000.0, down 95.1% year-over-year; the trailing twelve-month figure through Mar 2026 was 102656000.0 (up 9.7% YoY), and the FY2025 annual result was 81130000.0, up 33.88% from the prior year.
• Income from Continuing Operations came in at 44162000.0 for Q1 2026 at Zymeworks, down from 41209000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 309431000.0 in Q4 2022 to a low of 72625000.0 in Q1 2022.
• The 5-year median for Income from Continuing Operations is 29850000.0 (2024), against an average of 14254117.65.
• Across the five-year window, Income from Continuing Operations surged 890.33% in 2022 and plunged 104.68% in 2023, its largest moves.
• Zymeworks' Income from Continuing Operations stood at 309431000.0 in 2022, then slumped by 104.68% to 14482000.0 in 2023, then tumbled by 62.31% to 23506000.0 in 2024, then slumped by 75.31% to 41209000.0 in 2025, then fell by 7.17% to 44162000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 44162000.0 (Q1 2026), 41209000.0 (Q4 2025), and 19602000.0 (Q3 2025), per Business Quant data.